PRTA Q2 2017 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M+7951.7% YoY

Gross Profit

-$7M-26.9% margin

Operating Income

-$18M-67.6% margin

Net Income

-$18M-66.0% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

+10252.1%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$579M

Total Liabilities

$92M

Stockholders' Equity

$487M

Cash & Equivalents

$472M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$333,000	+7951.7%
Gross Profit	-$7M	-$32M	+77.5%
Operating Income	-$18M	-$40M	+54.9%
Net Income	-$18M	-$40M	+56.2%